Does Ozempic damage your liver?
No — current evidence indicates Ozempic improves liver health rather than damaging it. The ESSENCE Phase 3 trial of semaglutide for MASH showed liver stiffness improved more than weight loss alone could explain. The FDA approved semaglutide for MASH treatment in August 2025; the AASLD updated guidance in November 2025 to include it.
Transient liver enzyme rises (ALT, AST) can occur in the first 1–3 months as the liver responds to rapid weight loss. These usually settle and are not the same as drug-induced liver injury. Genuine hepatotoxicity from semaglutide is rare.
Do I need a liver scan before starting Ozempic?
Australian GP guidelines (MJA, September 2025) recommend a baseline FIB-4 blood test for all patients with metabolic risk factors — type 2 diabetes, BMI > 30, metabolic syndrome. If your FIB-4 is in the indeterminate range (1.3–2.67), elastography is the next step.
If your FIB-4 is reassuring and you have no other red flags, you don't need a pre-treatment liver scan. If it's indeterminate or high, get the elastography — it's a 10-minute, non-invasive test that produces an objective stiffness number you can track over time.
What Ozempic does to liver fat and fibrosis
Semaglutide reduces liver fat through three mechanisms: significant weight loss (10–15% of body weight is typical), direct action on GLP-1 receptors expressed in liver tissue, and improved insulin sensitivity that reduces the metabolic drive behind fatty liver.
In MASH trials, semaglutide produced histological MASH resolution in 62.9% of patients (vs 17% on placebo) and fibrosis improvement in 36.8%. Elastography stiffness reductions of 4–7 kPa at 12 months are common in responders.
Monitoring your liver on Ozempic — recommended schedule
- Baseline: FIB-4, LFTs (ALT, AST, GGT, ALP, bilirubin), platelets. Elastography if FIB-4 is indeterminate or high.
- Month 3: Repeat LFTs. Expect modest reductions in ALT/AST.
- Month 6: LFTs, weight, blood pressure.
- Month 12: Full repeat — FIB-4, LFTs, lipids, weight. Repeat elastography if it was indicated at baseline.
For elastography responders, a reduction of ≥5 kPa from baseline is considered clinically meaningful under Baveno VII criteria.
Frequently asked questions
Can Ozempic reverse fatty liver disease?
Trial data shows semaglutide significantly reduces liver fat in MASH patients — 62.9% achieved histological MASH resolution in the ESSENCE trial. Whether reversal is complete depends on baseline severity and ongoing metabolic control.
Should I get a FibroScan if I'm on Ozempic?
If you have type 2 diabetes, BMI over 30, or metabolic syndrome — and your FIB-4 score is indeterminate (1.3–2.67) — yes. FibroScan or guided elastography gives an objective baseline and a way to track response over time.
What happens to liver enzymes on Ozempic?
ALT and AST typically fall over the first 3–6 months as liver fat reduces. Transient mild elevations early on are not unusual and don't usually need investigation unless they're large or symptomatic.
How often should I monitor my liver on Ozempic?
Baseline FIB-4 and LFTs (plus elastography if indicated), then LFTs at 3 and 6 months, then full repeat at 12 months. Long-term, an annual check is sensible for at-risk patients.
Get a baseline liver scan near you
If your FIB-4 is indeterminate, a one-off elastography appointment gives you and your GP an objective baseline before or early in GLP-1 treatment.
This page is educational and not medical advice. Always discuss your GLP-1 treatment and liver monitoring with your GP.